Check out other ATMP opportunities around the conference!
Flemingsberg ATMP network Symposia
The Flemingsberg ATMP network is probably the largest local consortia of ATMP activity in Sweden. The local network includes the GMP/ATMP manufacture facility Vecura and associated Karolinska Centre for Cellular Therapies (KCC) as well as the Karolinska Institutet pre-GMP facility. Flemingsberg is also the first site in Sweden to treat a patient with market approved CAR-T therapy at the Centre for Allogenic Stem Cell Transplantation (CAST). Home of BOOSTB4, Procella Therapeutics AB, CellSeed AB, CellProtect Nordic Phamaceuticals, TCER AB, NextGenNK and NextCell Pharma, Flemingsberg is a dynamic player in the Swedish ATMP space.
This symposia presents the ATMP activities of Flemingsberg based; Fredrik Lanner, NextCell Pharma, Mikael Uhlin, Bo-Göran Ericzon, TCER, BOOSTB4 and CellProtect Nordic Pharmaceuticals.
Flemingsberg facility tours
We have had great interest in our facility tours, including Vecura, Karolinska Institutet pre-GMP and the Centre for Allogenic Stem Cell Transplantation (CAST). Due to this new registrations are no longer possible.
Healthcare workers and processes are essential to the success of ATMPs. This workshop is an intimate and targetted event for sharing and discussion of the practical aspects of implementing and delivering ATMPs.